Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,444 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline.
Visvanathan K, Hurley P, Bantug E, Brown P, Col NF, Cuzick J, Davidson NE, Decensi A, Fabian C, Ford L, Garber J, Katapodi M, Kramer B, Morrow M, Parker B, Runowicz C, Vogel VG 3rd, Wade JL, Lippman SM. Visvanathan K, et al. Among authors: parker b. J Clin Oncol. 2013 Aug 10;31(23):2942-62. doi: 10.1200/JCO.2013.49.3122. Epub 2013 Jul 8. J Clin Oncol. 2013. PMID: 23835710 Review.
Survival of In-Hospital Cardiopulmonary Arrest in Trauma Patients.
Collie BL, Emami S, Lyons NB, Ramsey WA, O'Neil CF Jr, Meizoso JP, Ginzburg E, Pizano LR, Schulman CI, Parker BM, Namias N, Proctor KG. Collie BL, et al. Among authors: parker bm. J Surg Res. 2024 Apr 25;298:379-384. doi: 10.1016/j.jss.2024.03.043. Online ahead of print. J Surg Res. 2024. PMID: 38669784
Practical deployment of automation to expedite aqueous two-phase extraction.
Torres-Acosta MA, Olivares-Molina A, Kent R, Leitão N, Gershater M, Parker B, Lye GJ, Dikicioglu D. Torres-Acosta MA, et al. Among authors: parker b. J Biotechnol. 2024 May 20;387:32-43. doi: 10.1016/j.jbiotec.2024.03.013. Epub 2024 Mar 28. J Biotechnol. 2024. PMID: 38555021 Free article.
Correction: a phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic HER2-negative breast cancer.
Shatsky RA, Batra-Sharma H, Helsten T, Schwab RB, Pittman EI, Pu M, Weihe E, Ghia EM, Rassenti LZ, Molinolo A, Cabrera B, Breitmeyer JB, Widhopf Ii GF, Messer K, Jamieson C, Kipps TJ, Parker BA. Shatsky RA, et al. Among authors: parker ba. Breast Cancer Res. 2024 Mar 13;26(1):46. doi: 10.1186/s13058-024-01805-w. Breast Cancer Res. 2024. PMID: 38481291 Free PMC article. No abstract available.
1,444 results